anti-Malondialdehyde [MDA], mAb (1F83)
| Code | Size | Price |
|---|
| JAI-MMD-030N-30ug | 30 ug | £781.00 |
Quantity:
Prices exclude any Taxes / VAT
Overview
Antibody Isotype: Mouse IgG2alambda
Antibody Clonality: Monoclonal
Antibody Clone: 1F83
Regulatory Status: RUO
Target Species: Human
Application: Immunohistochemistry (IHC)
Shipping:
BLUE ICE
Storage:
-20°C
Documents
Further Information
EClass:
32160000
Form (Short):
liquid
Formulation:
Frozen liquid. Contains 10mM PBS, 0.1% NaN3 and 0.5% BSA.
Handling Advice:
Avoid freeze/thaw cycles.
Immunogen:
MDA-modified keyhole-lympet hemocyanine.
Long Description:
Monoclonal Antibody. Recognizes MDA-modified proteins (especially DHP-lysine). Frozen liquid. Contains 10mM PBS, 0.1% NaN3 and 0.5% BSA. Malondialdehyde (MDA) is one of the major aldehyde derive from lipid peroxidation. MDA is highly reactive aldehyde and reacts with lysine residue in protein. The reaction with MDA and lysine residue leads to the formation of numerous numbers of adducts, such as dihydropyridine-lysine (DHP-lysine) type derivative.
Package Type:
Plastic Vial
Product Description:
Malondialdehyde (MDA) is one of the major aldehyde derive from lipid peroxidation. MDA is highly reactive aldehyde and reacts with lysine residue in protein. The reaction with MDA and lysine residue leads to the formation of numerous numbers of adducts, such as dihydropyridine-lysine (DHP-lysine) type derivative.
Specificity:
Recognizes MDA-modified proteins (especially DHP-lysine).
Transportation:
Non-hazardous
UNSPSC Category:
Primary Antibodies
UNSPSC Number:
12352203
Use & Stability:
Stable for at least 3 years after receipt when stored at -20°C.
References
Immunochemical detection of a lipofuscin-like fluorophore derivered from malondialdehyde and lysine: S. Yamada, et al.; J. Lipid Res. 42, 1187 (2001)
Related Products
| Product Name | Product Code | Supplier | anti-4-Hydroxy-2-nonenal [4-HNE], mAb (HNEJ-2) | JAI-MHN-020P | JaICA | Summary Details | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| anti-4-Hydroxy-2-nonenal [4-HNE], mAb (HNEJ-2) | JAI-MHN-100P | JaICA | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| anti-7-Ketocholesterol [7-KC], mAb (35A) | JAI-MKC-020N | JaICA | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| anti-Methylglyoxal [MG], mAb (3C) | JAI-MMG-030N | JaICA | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| anti-Nitrotryptophan (NW), mAb (117C) | JAI-MNW-020P | JaICA | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| anti-8-Hydroxy-2'-deoxyguanosine [8-OHdG], mAb (N45.1) | JAI-MOG-020P | JaICA | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||